Medivation (NASDAQ:MDVN) is one of today's biggest movers, up 2.4% to $59.40. The S&P is trading higher by 0.6% to 1,649 and the Dow is trading 0.5% higher to 14,904.
Medivation (NASDAQ:MDVN) has potential upside of 18.4% based on a current price of $59.40 and analysts' consensus price target of $70.33. Medivation shares have support at the 50-day moving average (MA) of $55.29 and additional support at the 200-day MA of $52.14.
Medivation Inc. acquires, develops, and sells or partners biomedical technologies in the early development stage of the research and development process.
In the past 52 weeks, shares of Medivation have traded between a low of $7.76 and a high of $59.86 and are now at $59.40, which is 666% above that low price. The 200-day and 50-day moving averages have moved 0.20% higher and 0.82% higher over the past week, respectively.